Careplus Group Berhad

KLSE:CAREPLS Stock Report

Market Cap: RM201.0m

Careplus Group Berhad Valuation

Is CAREPLS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Unter dem Marktwert

  • Deutlich unter dem Marktwert

  • Price-To-Sales gegen Gleichaltrige

  • Price-To-Sales gegen Industrie

  • PM vs. Fair Ratio

  • Analysten-Prognose

Share Price vs Fair Value

What is the Fair Price of CAREPLS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von CAREPLS für die Bewertungsanalyse.

Deutlich unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von CAREPLS für die Bewertungsanalyse.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CAREPLS?

Other financial metrics that can be useful for relative valuation.

CAREPLS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.9x
Enterprise Value/EBITDA-3.7x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CAREPLS's PS Ratio compare to its peers?

The above table shows the PS ratio for CAREPLS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.8x
COMFORT Comfort Gloves Berhad
0.8xn/aRM266.3m
ADVENTA Adventa Berhad
2.4xn/aRM88.6m
ONEGLOVE One Glove Group Berhad
5.1xn/aRM121.6m
SUPERMX Supermax Corporation Berhad
3x25.1%RM2.2b
CAREPLS Careplus Group Berhad
1xn/aRM201.0m

Price-To-Sales gegen Gleichaltrige: CAREPLS ist ein guter Wert, wenn man sein Price-To-Sales Verhältnis (1.1x) mit dem Durchschnitt der anderen Unternehmen (3.2x) vergleicht.


Price to Earnings Ratio vs Industry

How does CAREPLS's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a20.5%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a20.5%
n/an/an/a
No more companies

Price-To-Sales gegen Industrie: CAREPLS ist aufgrund seines Price-To-Sales Verhältnisses (1.1x) im Vergleich zum Asian Medical Equipment Branchendurchschnitt (3.2x) ein guter Wert.


Price to Sales Ratio vs Fair Ratio

What is CAREPLS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CAREPLS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1x
Fair PS Ration/a

PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von CAREPLS für die Bewertungsanalyse.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analysten-Prognose: Unzureichende Daten für eine Preisprognose.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.